CALL FOR ABSTRACTS
Coming soon
IMMUNOTHERAPY BRIDGE
December 4th - 5th, 2024
THE CALL FOR ABSTRACT IS NOW CLOSED. NOTIFICATIONS WILL BE SENT ON OCT 30TH
Immunotherapy Bridge Presidents are glad to invite the submission of abstracts for the presentation of oral communications and posters at next meeting held from December 4th to 5th
The themes of posters and oral presentations are:
Attendees are expected from all around the world and encouraged to submit their abstracts for poster or oral presentation during the Immunotherapy Bridge Congress.
The accepted abstract which have not been published elsewhere will be included in a dedicated Supplement of the Journal of Translational Medicine.
The themes of posters and oral presentations are:
- Biomarkers and Cell Therapies
- Immunotherapy beyond T cells
- Organ specific immune response
- NeoAdjuvant Immunotherapy across cancers
Attendees are expected from all around the world and encouraged to submit their abstracts for poster or oral presentation during the Immunotherapy Bridge Congress.
The accepted abstract which have not been published elsewhere will be included in a dedicated Supplement of the Journal of Translational Medicine.
Important Dates for Abstracts Submission:
Submission opening: Apr 15th, 2024
Submission deadline: Oct 10th, 2024
Notification: Oct 30th, 2024
Guidelines for authors
Submit your abstract as word file by e-mail to abstract@melanomabridge.org
Receipt of your abstract will be acknowledged by e-mail within a few days.
If acknowledgement is not received within one week of submission, please contact us again.
For information please contact abstract@melanomabridge.org.
Submission opening: Apr 15th, 2024
Submission deadline: Oct 10th, 2024
Notification: Oct 30th, 2024
Guidelines for authors
Submit your abstract as word file by e-mail to abstract@melanomabridge.org
Receipt of your abstract will be acknowledged by e-mail within a few days.
If acknowledgement is not received within one week of submission, please contact us again.
For information please contact abstract@melanomabridge.org.